Abstract
Ubiquitinated protein detection is often troublesome since in most cases this modification reduces the half-life of targeted proteins, inducing their degradation. Furthermore, ubiquitination is reversible thanks to the action of highly specific deubiquitinases present in all eukaryotic cells. MHC molecules ubiquitination has been demonstrated to be a key event in the regulation of the potent immunostimulatory properties of activated human dendritic cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pierre P et al (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388(6644):787–792
de Gassart A et al (2008) MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH1 down-regulation. Proc Natl Acad Sci 105(9):3491–3496
Shin J-S et al (2006) Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444(7115):115–118
van Niel G et al (2006) Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25(6):885–894
Komander D (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37(Pt 5):937–953
Baravalle G et al (2011) Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. J Immunol 187(6):2966–2973
Bartee E et al (2004) Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78(3):1109–1120
Goto E et al (2003) c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J Biol Chem 278(17):14657–14668
Ishido S et al (2009) E3 ubiquitin ligases for MHC molecules. Curr Opin Immunol 21(1):78–83
Toyomoto M et al (2011) Anti-arthritic effect of E3 ubiquitin ligase, c-MIR, expression in the joints. Int Immunol 23(3):177–183
Bania J et al (2003) Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc Natl Acad Sci U S A 100(11):6664–6669
Roche PA et al (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345(6276):615–618
Radka SF et al (1984) Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting. Hum Immunol 10(3):177–186
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
De Gassart, A., De Angelis Rigotti, F., Gatti, E. (2013). MHC-II Ubiquitination. In: van Endert, P. (eds) Antigen Processing. Methods in Molecular Biology™, vol 960. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-218-6_38
Download citation
DOI: https://doi.org/10.1007/978-1-62703-218-6_38
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-217-9
Online ISBN: 978-1-62703-218-6
eBook Packages: Springer Protocols